Holen Sie sich die Stockscreener-App
145.31
2.82%
-4.21
Vorhandelsmarkt:
144.00
-1.31
-0.90%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt BDX?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$149.52
Offen:
$148.3
24-Stunden-Volumen:
2.92M
Relative Volume:
1.10
Marktkapitalisierung:
$41.34B
Einnahmen:
$21.92B
Nettoeinkommen (Verlust:
$1.76B
KGV:
23.73
EPS:
6.1223
Netto-Cashflow:
$2.63B
1W Leistung:
-6.64%
1M Leistung:
-5.95%
6M Leistung:
-19.95%
1J Leistung:
-29.61%
1-Tages-Spanne:
$144.51
$148.58
1-Wochen-Bereich:
$144.51
$156.75
52-Wochen-Spanne:
$144.51
$213.08
Becton Dickinson Co Stock (BDX) Company Profile
Firmenname
Becton Dickinson Co
Sektor
Telefon
(201) 847-6800
Adresse
ONE BECTON DR, FRANKLIN LAKES
Compare BDX vs ISRG, MDLN, ALC, RMD
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
BDX
Becton Dickinson Co
|
145.31 | 42.53B | 21.92B | 1.76B | 2.63B | 6.1223 |
ISRG
Intuitive Surgical Inc
|
453.83 | 165.27B | 10.58B | 3.00B | 2.83B | 8.2437 |
MDLN
Medline Inc
|
43.40 | 37.41B | 28.43B | 1.16B | 1.26B | 1.4457 |
ALC
Alcon Inc
|
72.81 | 36.75B | 10.40B | 980.00M | 1.61B | 1.9749 |
RMD
Resmed Inc
|
211.93 | 31.63B | 5.40B | 1.49B | 1.78B | 10.12 |
Becton Dickinson Co Stock (BDX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-04-10 | Fortgesetzt | Goldman | Neutral |
| 2026-02-10 | Fortgesetzt | Barclays | Overweight |
| 2026-02-03 | Fortgesetzt | Citigroup | Buy |
| 2025-09-25 | Eingeleitet | RBC Capital Mkts | Sector Perform |
| 2025-05-22 | Herabstufung | Citigroup | Buy → Neutral |
| 2025-05-02 | Herabstufung | Goldman | Buy → Neutral |
| 2025-05-02 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2025-05-02 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2025-05-01 | Herabstufung | BofA Securities | Buy → Neutral |
| 2025-05-01 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2025-05-01 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2024-10-01 | Hochstufung | Citigroup | Neutral → Buy |
| 2024-05-30 | Eingeleitet | Goldman | Buy |
| 2023-07-24 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2023-05-30 | Fortgesetzt | Morgan Stanley | Overweight |
| 2023-05-05 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2023-04-12 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2023-01-03 | Hochstufung | BofA Securities | Neutral → Buy |
| 2022-12-12 | Hochstufung | Citigroup | Sell → Neutral |
| 2022-07-11 | Herabstufung | Citigroup | Neutral → Sell |
| 2022-06-24 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2022-03-18 | Fortgesetzt | Raymond James | Mkt Perform |
| 2022-03-02 | Fortgesetzt | BofA Securities | Neutral |
| 2021-12-08 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2021-08-06 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2021-05-25 | Eingeleitet | Barclays | Equal Weight |
| 2020-12-15 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2020-12-15 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2020-07-09 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2020-06-01 | Fortgesetzt | Goldman | Buy |
| 2020-03-05 | Eingeleitet | Citigroup | Neutral |
| 2020-02-07 | Herabstufung | Cowen | Outperform → Market Perform |
| 2020-02-07 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2020-02-07 | Herabstufung | Raymond James | Strong Buy → Outperform |
| 2020-02-06 | Herabstufung | Cowen | Outperform → Market Perform |
| 2020-01-08 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2019-05-13 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2018-12-07 | Eingeleitet | Deutsche Bank | Buy |
| 2018-10-16 | Eingeleitet | Barclays | Equal Weight |
| 2018-06-21 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2018-04-10 | Hochstufung | Citigroup | Neutral → Buy |
| 2018-01-19 | Fortgesetzt | BofA/Merrill | Buy |
| 2018-01-05 | Hochstufung | Citigroup | Sell → Neutral |
| 2018-01-05 | Eingeleitet | KeyBanc Capital Mkts | Overweight |
| 2018-01-03 | Eingeleitet | Evercore ISI | Outperform |
| 2017-12-29 | Bestätigt | Deutsche Bank | Buy |
Alle ansehen
Becton Dickinson Co Aktie (BDX) Neueste Nachrichten
Becton, Dickinson and Company (BDX) Updates By-laws to Enhance G - GuruFocus
Becton Dickinson & Co. stock underperforms Wednesday when compared to competitors - MarketWatch
MANGROVE PARTNERS IM, LLC's Becton Dickinson & Co(BDX) Holding History - GuruFocus
Insider Sell: Michael Feld Sells Shares of Becton Dickinson & Co (BDX) - GuruFocus
Becton Dickinson EVP Michael Feld sells $11,243 in stock - Investing.com
Becton Dickinson (NYSE: BDX) CRO sells 74 common shares in market trade - Stock Titan
Becton Dickinson & Co. stock underperforms Monday when compared to competitors - MarketWatch
Transforming Becton, Dickinson and Company’s global integration landscape - Capgemini
Piper Sandler Trims Becton Dickinson (BDX) PT on Model Revisions - Yahoo Finance
Becton Dickinson & Co. stock underperforms Friday when compared to competitors - MarketWatch
Becton Dickinson and Company (BDX): Gold Standard Defensive Stock - Yahoo Finance
XS276302639 Bond Price and Chart — DUS:XS276302639 - TradingView
Kanawha Capital Management LLC Sells 13,557 Shares of Becton, Dickinson and Company $BDX - MarketBeat
KLP Kapitalforvaltning AS Acquires 65,500 Shares of Becton, Dickinson and Company $BDX - MarketBeat
Becton, Dickinson and Company $BDX Stake Reduced by Boston Trust Walden Corp - MarketBeat
TABR Capital Management LLC Makes New $3.81 Million Investment in Becton, Dickinson and Company $BDX - MarketBeat
Becton Dickinson & Co. stock underperforms Tuesday when compared to competitors - MarketWatch
Ticino Wealth Takes $1.48 Million Position in Becton, Dickinson and Company $BDX - MarketBeat
Khaitan, Clifford Chance act on Becton Dickinson’s global spin-off of its biosciences and diagnostic solut.. - ETLegalWorld.com
Becton Dickinson and Co stock (US0758871091): Is its medtech diversification strong enough for stead - AD HOC NEWS
Deals tracker: Community Health Systems adds surgery centers - Modern Healthcare
What You Need to Know Ahead of Becton, Dickinson and Company's Earnings Release - Yahoo Finance
Becton, Dickinson and Company (BDX) Stock Analysis: A Look at Its 20.77% Potential Upside - DirectorsTalk Interviews
Busey Bank Decreases Position in Becton, Dickinson and Company $BDX - MarketBeat
Lobbying Update: $60,000 of BECTON DICKINSON AND COMPANY lobbying was just disclosed - Quiver Quantitative
Becton Dickinson Stock Offers Stability and Dividends for Investors - HarianBasis.co
RBC Capital Lowers Becton Dickinson Price Target to $175 - HarianBasis.co
KANAWHA CAPITAL MANAGEMENT LLC's Becton Dickinson & Co(BDX) Holding History - GuruFocus
Becton Dickinson & Co stock (US0758871091): Why Google Discover visibility now matters more for medt - AD HOC NEWS
Slocum Gordon & Co LLP Makes New $1.94 Million Investment in Becton, Dickinson and Company $BDX - MarketBeat
KBC Group NV Has $14.85 Million Stock Holdings in Becton, Dickinson and Company $BDX - MarketBeat
Becton Dickinson Wins Supply Chain Honors As Valuation Appears Undemanding - Yahoo Finance
Becton Dickinson & Co. stock outperforms competitors on strong trading day - MarketWatch
The Healthcare Stock Built for Investors Who Prioritize Capital Preservation - The Motley Fool
Piper Sandler Maintains Becton Dickinson & Co(BDX.US) With Hold Rating, Cuts Target Price to $159 - 富途牛牛
Only one medical supplier won all 3 new HIRC awards: BD - Stock Titan
Assetmark Inc. Boosts Holdings in Becton, Dickinson and Company $BDX - MarketBeat
RBC Capital Maintains Becton Dickinson & Co(BDX.US) With Hold Rating, Cuts Target Price to $175 - 富途牛牛
Third View Private Wealth LLC Takes $4.99 Million Position in Becton, Dickinson and Company $BDX - MarketBeat
Becton, Dickinson and Company $BDX Stock Holdings Lessened by Sumitomo Mitsui Trust Group Inc. - MarketBeat
Becton, Dickinson and Company’s Bilal Muhsin on the future of Connected Care - Gulf Business
Becton Dickinson And Co: A $5.3 Billion Quarter Signals Limited Growth Momentum - Smartkarma
Massachusetts Financial Services Co. MA Has $1.84 Billion Holdings in Becton, Dickinson and Company $BDX - MarketBeat
Goldman Sachs Maintains Becton Dickinson & Co(BDX.US) With Hold Rating, Cuts Target Price to $167 - 富途牛牛
Cardinal Capital Management Inc. Has $23.89 Million Stock Holdings in Becton, Dickinson and Company $BDX - MarketBeat
Becton, Dickinson and Company (BD) 8-K Filing April 2026 – Company Details, Registered Securities, and Contact Information - Minichart
Becton, Dickinson and Company (BDX) Announces Executive Retireme - GuruFocus
Rick Byrd to Retire from BD - Finviz
Becton Dickinson & Co. stock outperforms competitors despite losses on the day - MarketWatch
Richard E. Byrd to Retire as President of Interventional at Becton Dickinson - TradingView
After 25 years at BD, a top medical device executive will retire - Stock Titan
Finanzdaten der Becton Dickinson Co-Aktie (BDX)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.90%
1.11%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):